NYSEAMERICAN : CATX

Perspective Therapeutics, Inc. — Key statistics

Healthcare · Medical Devices · United States

Last price 1.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 131.27M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	131.27M
Enterprise Value	-101.64M

Dates

Measure	Value
Earnings Date	Nov 13, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	114.15M
Shares Outstanding	114.15M
Shares Change (YoY)	+29.45%
Shares Change (QoQ)	+16.45%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	55.45%
Float	70.82M

Ratios

Measure	Value
PE Ratio	n/a
Forward PE	n/a
PS Ratio	320.96
Forward PS	751.73
PB Ratio	0.41
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Evratios

Measure	Value
EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financialposition

Measure	Value
Current Ratio	6.61
Quick Ratio	6.49
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-410.60

Financialefficiency

Measure	Value
Return on Equity (ROE)	-39.57%
Return on Assets (ROA)	-22.28%
Return on Invested Capital (ROIC)	-26.22%
Return on Capital Employed (ROCE)	-35.23%
Weighted Average Cost of Capital (WACC)	14.18%
Revenue Per Employee	$2,464
Profits Per Employee	-$701,410
Employee Count	166
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Measure	Value
Income Tax	-793,000
Effective Tax Rate	n/a

Stockprice

Measure	Value
Beta (5Y)	1.85
52-Week Price Change	-57.88%
50-Day Moving Average	2.57
200-Day Moving Average	3.54
Relative Strength Index (RSI)	22.40
Average Volume (20 Days)	2,812,447

Shortselling

Measure	Value
Short Interest	16.68M
Short Previous Month	22.81M
Short % of Shares Out	14.61%
Short % of Float	23.55%
Short Ratio (days to cover)	6.96

Incomestatement

Measure	Value
Revenue	409,000
Gross Profit	-95.77M
Operating Income	-125.23M
Pretax Income	-117.42M
Net Income	-116.43M
EBITDA	-121.19M
EBIT	-125.23M
Loss Per Share	-$1.25

Balancesheet

Measure	Value
Cash & Cash Equivalents	236.88M
Total Debt	3.96M
Net Cash	232.91M
Net Cash Per Share	$2.04
Equity (Book Value)	323.86M
Book Value Per Share	2.84
Working Capital	204.98M

Cashflow

Measure	Value
Operating Cash Flow	-93.07M
Capital Expenditures	-28.12M
Depreciation & Amortization	4.05M
Net Borrowing	-54,000
Free Cash Flow	-121.19M
FCF Per Share	-$1.06

Margins

Measure	Value
Gross Margin	n/a
Operating Margin	-30,619.07%
Pretax Margin	-28,710.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-29.45%
Shareholder Yield	-29.45%
Earnings Yield	-108.58%
FCF Yield	-92.32%

Analystforecasts

Measure	Value
Price Target	$10.57
Price Target Difference	819.13%
Analyst Consensus	Strong Buy
Analyst Count	16
Revenue Growth Forecast (3Y)	-33.32%
EPS Growth Forecast (3Y)	n/a

Stocksplits

Measure	Value
Last Split Date	Jun 17, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Measure	Value
Altman Z-Score	1.15
Piotroski F-Score	2

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a